|
Follow the links below to find information about neuromuscular diseases.
Reviewed May 2008
Printer friendly page
Related HealthInsite Topics
| Results 1 to 10 displayed. |
| Title: |
Corticosteroids for myasthenia gravis
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Myasthenia gravis is caused by the body's antibodies impairing transmission of nerve impulses to muscles, resulting in fluctuating weakness and fatigue. Acute attacks can be life threatening because of swallowing or breathing difficulties. Limited evide...
|
| Date: |
Jan 2005
|
| Title: |
Piriformis syndrome
|
| Publisher: |
myDr
|
| Description: |
Piriformis syndrome involves the piriformis muscle of the buttock compressing and irritating the sciatic nerve.
|
| Date: |
Sep 2006
|
| Title: |
Immunosuppressive agents for myasthenia gravis
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Myasthenia gravis (MG) is caused by antibodies produced by the immune system that impair the transmission of nerve impulses to muscles. This results in muscle weakness that characteristically fluctuates. About one person in every 10 000 - 50 000 develop...
|
| Date: |
Aug 2007
|
| Title: |
Rehabilitation interventions for foot drop in neuromuscular disease
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Foot drop is the term commonly used to describe weakness or contracture of the muscles at the ankle joint. It may arise from many neuromuscular diseases. Interventions might include a 'wait and see' approach, physiotherapy, orthotics (appliances), surge...
|
| Date: |
Feb 2007
|
| Title: |
Myasthenia gravis: a patient's perspective
|
| Publisher: |
Australian Prescriber
|
| Description: |
Mark Latham was the United Nations representative in the Cape Verde Islands. He was 56 years old when he developed myasthenia gravis in 1998.
|
| Date: |
Dec 2007
|
| Title: |
Dental notes: treatment of myasthenia gravis
|
| Publisher: |
Australian Prescriber
|
| Description: |
The prevalence of myasthenia gravis (about 1 in 10 000 people) is such that every dentist will probably treat more than one patient with the condition during their career. Changes in tongue and facial muscle strength can often be the first sign of myasthenia gravis. These changes may impact on oral hygiene and the ability to wear dentures.
|
| Date: |
Dec 2007
|
| Title: |
Treatment of myasthenia gravis
|
| Publisher: |
Australian Prescriber
|
| Description: |
Myasthenia gravis is a syndrome of weakness and fatigue due to dysfunction of the neuromuscular junction. It is an antibody-mediated autoimmune condition with a range of moderately effective treatments. Occasionally patients go into remission spontaneously, but most require treatment. Mild disease, such as that confined to the ocular muscles, can often be treated with pyridostigmine alone.
|
| Date: |
Dec 2007
|
| Title: |
Medical mishap: serotonin syndrome precipitated by an over-the-counter cold remedy
|
| Publisher: |
Australian Prescriber
|
| Description: |
Serotonin syndrome is a triad of mental-status changes, autonomic hyperactivity, and neuromuscular abnormalities, with a mortality of about 11%. It is caused by excessive stimulation of serotonin receptors, often as a result of interactions between serotonergic drugs.
|
| Date: |
Jun 2006
|
| Results 1 to 10 displayed. |
|